Screener
Hemab Therapeutics Holdings, Inc. COAG Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Hemab Therapeutics Holdings, Inc.’s reported figures.
The source filing: Hemab Therapeutics Holdings, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344533
FAQ
- What is Hemab Therapeutics Holdings, Inc.'s enterprise value?
- Hemab Therapeutics Holdings, Inc. (COAG) reported enterprise value of $1.48B in Q2 2026.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Hemab Therapeutics Holdings, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude